\
&
Contact us
\
&
Contact us
Starts in 2 weeks from now
LocationOnline
ProgrammesThis webinar will offer a comprehensive introduction to the DUT Call 2025 and guidance on how to apply for funding.
Engage directly with the DUT Call Secretariat and get your questions answered during a Q&A session.
Representatives from participating funding agencies will also be present to explain country-specific rules and answer your questions during breakout sessions.
For more information on this online event and to register, please visit the dedicated event page via this link.
The Driving Urban Transitions (DUT) Partnership is an intergovernmental research and innovation programme addressing key challenges of urban transitions. The ambition is to shape and facilitate an innovation ecosystem that enables all urban actors to engage and benefit. With currently 67 partners from 28 countries, the DUT Partnership addresses the challenges which European cities face in their endeavour to become sustainable and enhance the quality of life for their citizens.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
